Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 2, 2013, Pages 274-280

  Burns, David L ^a   Gill, Brian M ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

3 fatty acids; cholestatic liver disease; Omegaven; parenteral fish oil; parenteral nutrition associated liver disease

Indexed keywords

ACETIC ACID; ALKALINE PHOSPHATASE; BILIRUBIN; FAMOTIDINE; FISH OIL; GLUCONATE CALCIUM; GLUCOSE; INTRALIPID; MAGNESIUM SULFATE; MULTIVITAMIN; OMEGA 3 FATTY ACID; OMEGAVEN; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; SOYBEAN OIL EMULSION; TRACE ELEMENT; TRAVASOL; URSODEOXYCHOLIC ACID;

ACUTE ABDOMEN; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CASE REPORT; CHOLECYSTECTOMY; CHOLESTASIS; FATIGUE; FATTY LIVER; FEMALE; HOME CARE; HUMAN; INTESTINE VOLVULUS; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION TEST; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALAISE; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PRIORITY JOURNAL; ULTRASOUND;

DIETARY FATS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; LIVER DISEASES; MIDDLE AGED; PARENTERAL NUTRITION, HOME; PARENTERAL NUTRITION, TOTAL; SHORT BOWEL SYNDROME; SOYBEAN OIL; UNITED STATES;

EID: 84873693508     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112450301     Document Type: Article

References (64)

1. Howard L, Ament M, Fleming CR, Shike M, Steiger E. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology. 1995 ; 109 (2). 355-365
2. Buchman AL. Complications of long-term home total parenteral nutrition: their identification, prevention and treatment. Dig Dis Sci. 2001 ; 46 (1). 1-18 (Pubitemid 32221832)
3. Freund HR. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition. 1991 ; 7 (1). 1-5
4. Buchman A. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2002 ; 26 (5). S43 - S48
5. Zambrano E, El-Hennawy M, Ehrenkranz RA, Zelterman D, Reyes-Mugica M. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol. 2004 ; 7 (5). 425-432 (Pubitemid 40385233)
6. Kelly DA. Liver complications of pediatric parenteral nutrition - epidemiology. Nutrition. 1998 ; 14 (1). 153-157 (Pubitemid 28049003)
7. Moss RL, Amii LA. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg. 1999 ; 8 (3). 140-147 (Pubitemid 29386060)
8. Cole CR, Frem JC, Schmotzer B, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr. 2010 ; 156 (6). 941-947
9. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1998 ; 27 (2). 131-137 (Pubitemid 28354942)
10. Wolf A, Pohlandt F. Bacterial infection: the main cause of acute cholestasis in newborn infants receiving short-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1989 ; 8 (3). 297-303 (Pubitemid 19087949)
11. Black DD, Suttle EA, Whitington PF, Whitington GL, Korones SD. The effect of short-term total parenteral nutrition on hepatic function in the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function. J Pediatr. 1981 ; 99 (3). 445-449 (Pubitemid 11029951)
12. Messing B, Colombel JF, Heresbach D, Chazouilleres O, Galian A. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition. 1992 ; 8 (1). 30-36
13. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology. 1996 ; 111 (3). 716-719 (Pubitemid 26293237)
14. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab. 1999 ; 12 (4). 549-553 (Pubitemid 29334735)
15. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J Pediatr. 2004 ; 145 (3). 317-321
16. San Luis VA, Btaiche IF. Ursodiol in patients with parenteral nutrition-associated cholestasis. Ann Pharmacother. 2007 ; 41 (11). 1867-1872 (Pubitemid 350044350)
17. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250 (3). 395-402
18. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 ; 118 (1). e197 - e201
19. Rangel SJ, Calkins CM, Cowles RA, et al. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2012 ; 47 (1). 225-240
20. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121 (3). e678 - e686
21. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009 ; 48 (2). 209-215
22. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998 ; 14 (1). 158-164 (Pubitemid 28049004)
23. Grimminger F, Wahn H, Mayer K, Kiss L, Walmrath D, Seeger W. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med. 1997 ; 155 (2). 513-519 (Pubitemid 27085794)
24. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007 ; 85 (5). 1171-1184 (Pubitemid 46740457)
25. Schmocker C, Weylandt KH, Kahlke L, et al. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology. 2007 ; 45 (4). 864-869 (Pubitemid 46631554)
26. Fallon EM, Le HD, Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant. 2010 ; 15 (3). 334-340
27. Bellenger J, Bellenger S, Clement L, et al. A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension. Faseb J. 2004 ; 18 (6). 773-775
28. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33 (5). 541-547
29. Venick RS, Calkins K. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2011 ; 16 (3). 306-311
30. Xiong J, Zhu S, Zhou Y, Wu H, Wang C. Regulation of omega-3 fish oil emulsion on the SIRS during the initial stage of severe acute pancreatitis. J Huazhong Univ Sci Technolog Med Sci. 2009 ; 29 (1). 35-38
31. Wang X, Li W, Li N, Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr. 2008 ; 32 (3). 236-241 (Pubitemid 351571258)
32. Pluess TT, Hayoz D, Berger MM, et al. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med. 2007 ; 33 (5). 789-797 (Pubitemid 46675326)
33. Khor BS, Liaw SJ, Shih HC, Wang LS. Randomized, double blind, placebo-controlled trial of fish-oil-based lipid emulsion infusion for treatment of critically ill patients with severe sepsis. Asian J Surg. 2011 ; 34 (1). 1-10
34. Beath SV, Davies P, Papadopoulou A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996 ; 31 (4). 604-606 (Pubitemid 26115658)
35. Campos AC, Oler A, Meguid MM, Chen TY. Liver biochemical and histological changes with graded amounts of total parenteral nutrition. Arch Surg. 1990 ; 125 (4). 447-450 (Pubitemid 20119139)
36. Meguid MM, Chen TY, Yang ZJ, Campos AC, Hitch DC, Gleason JR. Effects of continuous graded total parenteral nutrition on feeding indexes and metabolic concomitants in rats. Am J Physiol. 1991 ; 260 (1). E126 - E140
37. Li S, Nussbaum MS, Teague D, Gapen CL, Dayal R, Fischer JE. Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res. 1988 ; 44 (6). 639-648
38. Kaminski DL, Adams A, Jellinek M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery. 1980 ; 88 (1). 93-100 (Pubitemid 10086998)
39. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000 ; 132 (7). 525-532 (Pubitemid 30171891)
40. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990 ; 11 (1). 74-80 (Pubitemid 20075105)
41. Mullick FG, Moran CA, Ishak KG. Total parenteral nutrition: a histopathologic analysis of the liver changes in 20 children. Mod Pathol. 1994 ; 7 (2). 190-194
42. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999 ; 126 (1). 28-34 (Pubitemid 29340688)
43. Javid PJ, Collier S, Richardson D, et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg. 2005 ; 40 (6). 1015-1018 (Pubitemid 40840821)
44. Carter BA, Karpen SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis. 2007 ; 27 (3). 251-258 (Pubitemid 47301765)
45. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009 ; 19 (6). 348-353
46. Meehan JJ, Georgeson KE. Prevention of liver failure in parenteral nutrition: children with short bowel syndrome. J Pediatr Surg. 1997 ; 32 (3). 473-475
47. Vanderhoof JA, Langnas AN. Short-bowel syndrome in children and adults. Gastroenterology. 1997 ; 113 (5). 1767-1778 (Pubitemid 27461267)
48. Beau P, Labat-Labourdette J, Ingrand P, Beauchant M. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?. J Hepatol. 1994 ; 20 (2). 240-244 (Pubitemid 24086839)
49. Arslanoglu S, Moro GE, Tauschel HD, Boehm G. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr. 2008 ; 46 (2). 228-231 (Pubitemid 351161137)
50. Gleghorn EE, Merritt RJ, Subramanian N, Ramos A. Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates. JPEN J Parenter Enteral Nutr. 1986 ; 10 (3). 282-283 (Pubitemid 16063389)
51. Fiel MI, Sauter B, Wu HS, et al. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol. 2008 ; 6 (8). 926-933
52. Reimund JM, Arondel Y, Joly F, Messing B, Duclos B, Baumann R. Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease. Clin Nutr. 2004 ; 23 (6). 1418-1425 (Pubitemid 39517636)
53. Chen WJ, Yeh SL. Effects of fish oil in parenteral nutrition. Nutrition. 2003 ; 19 (3). 275-279
54. Alwayn IP, Gura K, Nose V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 ; 57 (3). 445-452 (Pubitemid 40293615)
55. Araya J, Rodrigo R, Videla LA, et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2004 ; 106 (6). 635-643 (Pubitemid 38797577)
56. Van Aerde JE, Duerksen DR, Gramlich L, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res. 1999 ; 45 (2). 202-208 (Pubitemid 29075996)
57. Meisel JA, Le HD, de Meijer VE, et al. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011 ; 46 (4). 666-673
58. Calder PC. n-3 fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids. 2004 ; 39 (12). 1147-1161
59. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005 ; 40 (5). 755-762 (Pubitemid 40724842)
60. Teitelbaum DH, Tracy TF, Aouthmany MM, et al. Use of cholecystokinin- octapeptide for the prevention of parenteral nutrition-associated cholestasis. Pediatrics. 2005 ; 115 (5). 1332-1340 (Pubitemid 43843240)
61. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 ; 66 (6). 698-703
62. Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2010 ; 34 (5). 477-484
63. de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 ; 50 (2). 212-218
64. Strijbosch RA, Lee S, Arsenault DA, et al. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism. 2008 ; 57 (5). 698-707 (Pubitemid 351608232)